These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 7803428
1. Acute rejection: significance of elapsed time after transplantation. Rizeq MN, Masek MA, Billingham ME. J Heart Lung Transplant; 1994; 13(5):862-8. PubMed ID: 7803428 [Abstract] [Full Text] [Related]
3. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy. Cantarovich M, Latter DA, Loertscher R. Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721 [Abstract] [Full Text] [Related]
5. Cytoimmunologic monitoring as an adjunct in monitoring rejection after heart transplantation: results of a 6-year follow-up in heart transplant recipients. Wijngaard PL, Doornewaard H, van der Meulen A, Plomp S, Gmelig Meyling FH, de Jonge N, Schuurman HJ. J Heart Lung Transplant; 1994 Aug; 13(5):869-75. PubMed ID: 7803429 [Abstract] [Full Text] [Related]
6. Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft. Milano A, Caforio AL, Livi U, Bauce B, Angelini A, Casarotto D, Thiene G. J Heart Lung Transplant; 1996 May; 15(5):456-60. PubMed ID: 8771500 [Abstract] [Full Text] [Related]
7. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. McNamara D, Di Salvo T, Mathier M, Keck S, Semigran M, Dec GW. J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506 [Abstract] [Full Text] [Related]
9. Quantitative short-tandem repeat analysis of recipient-derived cells as an additional tool for diagnosing cardiac allograft rejection. Pichler M, Beckendorf J, Winter E, Kleinert R, Kniepeiss D, Hoefler G. Transplantation; 2010 Mar 27; 89(6):749-55. PubMed ID: 19997059 [Abstract] [Full Text] [Related]
10. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ, Rossi AF, Courtney M, Gelb BD. J Heart Lung Transplant; 1998 Dec 27; 17(12):1195-200. PubMed ID: 9883760 [Abstract] [Full Text] [Related]
12. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation. McVicar JP, Kowdley KV, Emond MJ, Barr D, Marsh CL, Carithers RL, Perkins JD. Clin Transplant; 1997 Aug 27; 11(4):328-33. PubMed ID: 9267724 [Abstract] [Full Text] [Related]
13. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases]. Cherqui D, Duvoux C, Charlotte F, Humeres R, Lauzet JY, Métreau JM, Salvat A, Rotman N, Julien M, Fagniez PL. Gastroenterol Clin Biol; 1994 Aug 27; 18(2):115-22. PubMed ID: 8013792 [Abstract] [Full Text] [Related]
14. A semiquantitative approach to the evaluation of acute cardiac allograft rejection at endomyocardial biopsy. Frigerio M, Bonacina E, Gronda E, Andreuzzi B, Anjos MC, De Vita C, Mangiavacchi M, Masciocco G, Oliva F, Pellegrini A. J Heart Lung Transplant; 1997 Nov 27; 16(11):1087-98. PubMed ID: 9402507 [Abstract] [Full Text] [Related]
18. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation. Zwirska-Korczala K, Zakliczyński M, Berdowska A, Zembala M, Jochem J, Gajewska K. J Heart Lung Transplant; 2005 Apr 27; 24(4):411-5. PubMed ID: 15797741 [Abstract] [Full Text] [Related]